The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer

BACKGROUND: Aberrant methylation of EphA7 has been reported in the process of carcinogenesis but not in cervical cancer. Therefore, an integration study was performed to explore the association between EphA7 hypermethylation and cervical cancer and validate the potential value of EphA7 hypermethylat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenfan, Cao, Huiling, Yang, Jinhao, Zhao, Jing, Liang, Zheng, Kang, Xiaodong, Wang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185921/
https://www.ncbi.nlm.nih.gov/pubmed/35681118
http://dx.doi.org/10.1186/s12885-022-09653-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185921/
https://www.ncbi.nlm.nih.gov/pubmed/35681118
http://dx.doi.org/10.1186/s12885-022-09653-7

Ejemplares similares